← MSB

MSBMESOBLAST LIMITED

Announcement history available from 1 August 2025

Fromto
Date / TimeTitleTypeMSReport Codes
17 Aug 2026, 20:00Major Milestone Treatment Completed in P3 Trial for CLBPCompany UpdateMS11001
14 Aug 2026, 03:52Becoming a substantial holderSubstantial Holders—02001
8 Aug 2026, 03:02Ceasing to be a substantial holderSubstantial Holders—02003
6 Aug 2026, 04:29Becoming a substantial holderSubstantial Holders—02001
4 Aug 2026, 03:25Ceasing to be a substantial holderSubstantial Holders—02003
1 Aug 2026, 03:06Becoming a substantial holderSubstantial Holders—02001
30 July 2026, 20:01Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly ReportsMS19004, 19009
25 July 2026, 03:00Ceasing to be a substantial holderSubstantial Holders—02003
22 July 2026, 18:23Ceasing to be a substantial holderSubstantial Holders—02003
21 July 2026, 19:53Mesoblast CEO Makes Investment to Increase Share OwnershipSubstantial Holders—02006, 06009
21 July 2026, 19:47Appendix 3Y - Silviu ItescuDirector Interests—02009
21 July 2026, 19:43Notification regarding unquoted securities - MSBOther—06021
21 July 2026, 19:33Application for quotation of securities - MSBOther—06020
15 July 2026, 03:31Notification of cessation of securities - MSBOther—06027
15 July 2026, 03:25Notification regarding unquoted securities - MSBOther—06021
15 July 2026, 03:21Application for quotation of securities - MSBOther—06020
15 July 2026, 03:15Notification regarding unquoted securities - MSBOther—06021
15 July 2026, 03:12Appendix 3Y - Silviu ItescuDirector Interests—02009
14 July 2026, 20:00Pivotal Phase 3 Trial in CLBP Achieves 300 Treated PatientsCompany UpdateMS11001
10 July 2026, 19:57Ryoncil Q4 Net Revenue of US$36M and US$115M for Full YearPeriodic ReportsMS03014
1 July 2026, 19:56Receives FDA BLA Filing Number and Requests Modular ReviewCompany Update—11001
30 June 2026, 18:13Becoming a substantial holderSubstantial Holders—02001
29 June 2026, 18:18Ceasing to be a substantial holderSubstantial Holders—02003
25 June 2026, 19:55Mesoblast Draws US$50M from Five-Year Non-Dilutive FacilityCapital RaisingMS03022
16 June 2026, 18:18Becoming a substantial holderSubstantial Holders—02001
12 June 2026, 18:23Ceasing to be a substantial holderSubstantial Holders—02003
2 June 2026, 21:51ASX CEO Connect PresentationPresentations—03026
30 Apr 2026, 19:56Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly ReportsMS19003, 19008
29 Apr 2026, 19:50Patient Recruitment Target Achieved in CLBP Pivotal TrialCompany UpdateMS11001
17 Apr 2026, 03:22Appendix 3Y for Gregory GeorgeDirector Interests—02009
17 Apr 2026, 03:13Notification of cessation of securities - MSBOther—06027
17 Apr 2026, 03:09Notification regarding unquoted securities - MSBOther—06021
17 Apr 2026, 03:05Application for quotation of securities - MSBOther—06020
17 Apr 2026, 03:03Notification regarding unquoted securities - MSBOther—06021
15 Apr 2026, 19:25Acquires CAR Platform for Precision-Enhanced Cell ProductsMergers & Acquisitions—07001
9 Apr 2026, 05:16Mesoblast R&D Day PresentationPresentations—03026
9 Apr 2026, 05:08Mesoblast R&D Day Features Commercial & Blockbuster ProgramsPresentations—12008, 14014
8 Apr 2026, 22:31FDA Clears Ryoncil IND for Registration Trial in DMDCompany Update—11001
8 Apr 2026, 20:00Application for quotation of securities - MSBOther—06020
8 Apr 2026, 19:54Cleansing NoticeSecurities Administration—06018
8 Apr 2026, 03:19Proposed issue of securities - MSBSecurities Administration—06013
7 Apr 2026, 20:12Ryoncil Net Revenue for the Quarter Increases to US$30.3MCompany UpdateMS11001, 14014
21 Mar 2026, 04:23Appendix 3Ys - S Itescu, E Rose, G George and L CobleyDirector Interests—02009
21 Mar 2026, 03:51Notification regarding unquoted securities - MSBOther—06021
18 Mar 2026, 20:54Mesoblast to Host R&D Day on April 8, 2026Presentations—12008, 14014
13 Mar 2026, 04:05Replacement Appendix 3Y for Gregory GeorgeDirector Interests—02009
12 Mar 2026, 20:58Appointment of Clinical Development and Medical Affairs HeadCompany Administration—12008
11 Mar 2026, 02:28Becoming a substantial holderSubstantial Holders—02001
10 Mar 2026, 20:39Appendix 3Y for Gregory GeorgeDirector Interests—02009
9 Mar 2026, 22:33Change in substantial holdingSubstantial Holders—02002
1–50 of 124
1 / 3